Nxstage Medical, Inc. (NXTM)

[surf1944]

7:27AM Nxstage Medical beats by $0.01, beats on revs; guides Q1 EPS below consensus, revs in-line; guides FY12 EPS, revs below consensus (NXTM) 20.36 : Reports Q4 (Dec) loss of $0.08 per share, $0.01 better than the Capital IQ Consensus Estimate of ($0.09); revenues rose 14.5% year/year to $57 mln vs the $56.25 mln consensus. Co issues guidance for Q1, sees EPS of ($0.09)-(0.11) vs. ($0.06) Capital IQ Consensus Estimate; sees Q1 revs of $56-57 mln vs. $56.94 mln Capital IQ Consensus Estimate. Co issues downside guidance for FY12, sees EPS of ($0.25)-(0.32) vs. ($0.13) Capital IQ Consensus Estimate; sees FY12 revs of $240-245 mln vs. $245.39 mln Capital IQ Consensus Estimate.